Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Antonio Vitale, Valeria Caggiano, Virginia Berlengiero, Maria Orsetta Perfetti, Jurgen Sota, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2023) Comparing biologic options for the management of Behcet’s disease-related uveitis. Expert Review of Clinical Immunology 19:3, pages 315-328.
Read now
Read now
Minghang Pei, Chan Zhao, Fei Gao, Yi Qu, Anyi Liang, Junyan Xiao & Meifen Zhang. (2021) Analysis of Parafoveal Microvascular Abnormalities in Behcet’s Uveitis Using Projection-Resolved Optical Coherence Tomographic Angiography. Ocular Immunology and Inflammation 29:3, pages 524-529.
Read now
Read now
Giuseppe Lopalco, Donato Rigante, Antonio Lopalco, Giacomo Emmi, Vincenzo Venerito, Antonio Vitale, Giovanna Capozio, Nunzio Denora, Luca Cantarini & Florenzo Iannone. (2020) Safety of systemic treatments for Behçet’s syndrome. Expert Opinion on Drug Safety 19:10, pages 1269-1301.
Read now
Read now
Rbab Taha, Hadeel El-Haddad, Abdulqader Almuallim, Fatma Alshaiki, Elaf Obaid & Hani Almoallim. (2017) Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch–Schönlein purpura, ankylosing spondylitis, and Raynaud’s phenomenon. Open Access Rheumatology: Research and Reviews 9, pages 201-214.
Read now
Read now
Antonio Vitale, Donato Rigante, Giuseppe Lopalco, Giacomo Emmi, Maria Teresa Bianco, Mauro Galeazzi, Florenzo Iannone & Luca Cantarini. (2016) New therapeutic solutions for Behçet’s syndrome. Expert Opinion on Investigational Drugs 25:7, pages 827-840.
Read now
Read now
Robert J Barry, Quan Dong Nguyen, Richard W Lee, Philip I Murray & Alastair K Denniston. (2014) Pharmacotherapy for uveitis: current management and emerging therapy. Clinical Ophthalmology 8, pages 1891-1911.
Read now
Read now
Sirichai Pasadhika & James T Rosenbaum. (2014) Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics: Targets and Therapy 8, pages 67-81.
Read now
Read now
Uwe Pleyer & Nicole Stübiger. (2014) New pharmacotherapy options for noninfectious posterior uveitis. Expert Opinion on Biological Therapy 14:12, pages 1783-1799.
Read now
Read now
Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth & C Stephen Foster. (2014) A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. Expert Opinion on Biological Therapy 14:11, pages 1651-1666.
Read now
Read now
Manfred Zierhut, Ahmet M. Abu El-Asrar, Bahram Bodaghi & Ilknur Tugal-Tutkun. (2014) Therapy of Ocular Behçet Disease. Ocular Immunology and Inflammation 22:1, pages 64-76.
Read now
Read now
Nicholas A Barnes, Maya H Buch & Michael F McDermott. (2013) Use of gevokizumab for the treatment of Behçet's disease. Expert Opinion on Orphan Drugs 1:9, pages 755-763.
Read now
Read now
Tamer A. Gheita, Hala Raafat, Hossam Khalil & Hani Hussein. (2013) Serum level of APRIL/BLyS in Behçet’s disease patients: clinical significance in uveitis and disease activity. Modern Rheumatology 23:3, pages 542-546.
Read now
Read now
Anna Dastiridou, Christos Kalogeropoulos, Periklis Brazitikos, Chrysanthos Symeonidis & Sofia Androudi. (2012) New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment
. Expert Review of Clinical Pharmacology 5:5, pages 543-555.
Read now
Read now
Jangwon Heo, Yasir J Sepah, Jithin Yohannan, Morgan Renner, Abeer Akhtar, Anthony Gregory, Mathew Shulman, Diana V Do & Quan Dong Nguyen. (2012) The role of biologic agents in the management of non-infectious uveitis. Expert Opinion on Biological Therapy 12:8, pages 995-1008.
Read now
Read now
Nicole R. Benitah, Lucia Sobrin & George N. Papaliodis. (2011) The Use of Biologic Agents in the Treatment of Ocular Manifestations of Behcet’s Disease. Seminars in Ophthalmology 26:4-5, pages 295-303.
Read now
Read now
Theresa Larson, Robert B Nussenblatt & H Nida Sen. (2011) Emerging drugs for uveitis. Expert Opinion on Emerging Drugs 16:2, pages 309-322.
Read now
Read now
Frank F Lee & Charles Stephen Foster. (2010) Pharmacotherapy of uveitis. Expert Opinion on Pharmacotherapy 11:7, pages 1135-1146.
Read now
Read now
Articles from other publishers (43)
Paola A. Rivera, Akash Gupta & Ninani Kombo. (2023) Treatment of non-infectious retinal vasculitis. Therapeutic Advances in Ophthalmology 15, pages 251584142311527.
Crossref
Crossref
Faruque Ghanchi, Rupert Bourne, Susan M. Downes, Richard Gale, Christina Rennie, Ian Tapply & Sobha Sivaprasad. (2022) An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma. Eye 36:6, pages 1154-1167.
Crossref
Crossref
Simple GuptaK. ShyamsundarMohini Agrawal, Nitin VichareJyotirmay Biswas. (2022) Current Knowledge of Biologics in Treatment of Noninfectious Uveitis. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 203-222.
Crossref
Crossref
Petros Efthimiou, Olga Petryna, Priscila Nakasato & Apostolos Kontzias. (2022) New insights on multigenic autoinflammatory diseases. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211178.
Crossref
Crossref
Caleb C. Ng, Aileen Sy & Emmett T. CunninghamJrJr. (2021) Rituximab for non-infectious Uveitis and Scleritis. Journal of Ophthalmic Inflammation and Infection 11:1.
Crossref
Crossref
Uwe Pleyer, Piergiorgio Neri & Christoph Deuter. (2021) New pharmacotherapy options for noninfectious posterior uveitis. International Ophthalmology 41:6, pages 2265-2281.
Crossref
Crossref
Ahmad Al-Moujahed, Doan Luong Hien, Amir Akhavanrezayat, Brandon Huy Pham, Than Trong Tuong Ngoc, Huy Luong Doan, Çigdem Yaşar, Sherin Lajevardi, Huy Vu Nguyen & Quan Dong Nguyen. (2021) Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behçet's disease. American Journal of Ophthalmology Case Reports 21, pages 101027.
Crossref
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis
326
349
.
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis
73
102
.
Vedat Hamuryudan, Ina Kötter & Hasan Tüzün. 2020. Behçet Syndrome. Behçet Syndrome
279
305
.
Donglei Zhang, Jieying Qin, Lin Li, Guannan Su, Guo Huang, Qingfeng Cao, Aize Kijlstra & Peizeng Yang. (2018) Analysis of the association between Fc receptor family gene polymorphisms and ocular Behçet’s disease in Han Chinese. Scientific Reports 8:1.
Crossref
Crossref
Jurgen Sota, Donato Rigante, Giuseppe Lopalco, Bruno Frediani, Rossella Franceschini, Mauro Galeazzi, Florenzo Iannone, Gian Marco Tosi, Claudia Fabiani & Luca Cantarini. (2017) Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review. Rheumatology International 38:1, pages 25-35.
Crossref
Crossref
Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston & Robert J. Barry. (2017) An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review. Orphanet Journal of Rare Diseases 12:1.
Crossref
Crossref
Radgonde Amer, Hilal Nalcı & Nilüfer Yalçındağ. (2017) Exudative retinal detachment. Survey of Ophthalmology 62:6, pages 723-769.
Crossref
Crossref
D. P. Kidd. (2017) Neurological complications of Behçet’s syndrome. Journal of Neurology 264:10, pages 2178-2183.
Crossref
Crossref
Shivakumar Mallappa, Kaushal Kumar, Soumyadeep Hazra & Moumita Hazra. (2017) A CASE REPORT OF RETINAL VASCULITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Journal of Evidence Based Medicine and Healthcare 4:76, pages 4503-4506.
Crossref
Crossref
Isil Bulur & Meltem Onder. (2017) Behçet disease: New aspects. Clinics in Dermatology 35:5, pages 421-434.
Crossref
Crossref
Harold ChenHarold Chen. 2017. Atlas of Genetic Diagnosis and Counseling. Atlas of Genetic Diagnosis and Counseling
271
281
.
Sumru Onal & Ilknur Tugal-Tutkun. 2016. Uveitis: An Update. Uveitis: An Update
17
31
.
Sofia Androudi, Anna Dastiridou & Manfred Zierhut. 2016. Intraocular Inflammation. Intraocular Inflammation
385
397
.
John Anthonypillai & Julian L. Ambrus. 2016. Systemic Vasculitides: Current Status and Perspectives. Systemic Vasculitides: Current Status and Perspectives
407
423
.
Harold ChenHarold Chen. 2016. Atlas of Genetic Diagnosis and Counseling. Atlas of Genetic Diagnosis and Counseling
1
11
.
D. P. Kidd. (2015) Rituximab is effective in severe treatment-resistant neurological Behçet’s syndrome. Journal of Neurology 262:12, pages 2676-2677.
Crossref
Crossref
Gabriele Simonini, Rolando Cimaz, Gareth T. Jones & Gary J. Macfarlane. (2015) Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review. Seminars in Arthritis and Rheumatism 45:2, pages 238-250.
Crossref
Crossref
Salvador Mérida, Elena Palacios, Amparo Navea & Francisco Bosch-Morell. (2015) New Immunosuppressive Therapies in Uveitis Treatment. International Journal of Molecular Sciences 16:8, pages 18778-18795.
Crossref
Crossref
Giulia Pazzola, Francesco Muratore, Nicolò Pipitone & Carlo Salvarani. (2015) Biologics in vasculitides: Where do we stand, where do we go from now?. La Presse Médicale 44:6, pages e231-e239.
Crossref
Crossref
Silke Hausberger, Beate-Julia Langner-Wegscheider & Andreas Wedrich. (2015) Morbus Adamantiades-Behçet bei einer 29-jährigen PatientinMorbus Adamantiades-Behçet in a 29-year old female patient. Spektrum der Augenheilkunde 29:3, pages 115-117.
Crossref
Crossref
Claudia Castiblanco & C. Stephen Foster. (2014) Review of Systemic Immunosuppression for Autoimmune Uveitis. Ophthalmology and Therapy 3:1-2, pages 17-36.
Crossref
Crossref
Cloé Comarmond, Bertrand Wechsler, Bahram Bodaghi, Patrice Cacoub & David Saadoun. (2014) Biotherapies in Behçet's disease. Autoimmunity Reviews 13:7, pages 762-769.
Crossref
Crossref
M. J. Messina, M. Rodegher, R. Scotti & V. Martinelli. (2014) Treatment of myelitis in Behcet's disease with rituximab. Case Reports 2014:may30 2, pages bcr2014204366-bcr2014204366.
Crossref
Crossref
Zeinab Saleh & Thurayya Arayssi. (2014) Update on the therapy of Behçet disease. Therapeutic Advances in Chronic Disease 5:3, pages 112-134.
Crossref
Crossref
Marina Mesquida, Blanca Molins, Victor Llorenç, María Victoria Hernández, Gerard Espinosa, Andrew D. Dick & Alfredo Adán. (2013) Current and future treatments for Behçet’s uveitis: road to remission. International Ophthalmology 34:2, pages 365-381.
Crossref
Crossref
C. Comarmond, B. Wechsler, P. Cacoub & D. Saadoun. (2014) Traitement de la maladie de Behçet. La Revue de Médecine Interne 35:2, pages 126-138.
Crossref
Crossref
Laura Pelegrin, Eva Jakob, Annette Schmidt-Bacher, Vedat Schwenger, Matthias Becker, Regina Max, Hans Martin Lorenz & Friederike Mackensen. (2014) Experiences with Rituximab for the Treatment of Autoimmune Diseases with Ocular Involvement. The Journal of Rheumatology 41:1, pages 84-90.
Crossref
Crossref
Barbara Hong Zhao & Anna Elfiky Oswald. (2013) Improved clinical control of a challenging case of Behçet’s disease with rituximab therapy. Clinical Rheumatology 33:1, pages 149-150.
Crossref
Crossref
Katherine J Donnithorne, Russell W Read, Robert Lowe, Peter Weiser, Randy Q Cron & Timothy Beukelman. (2013) Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. Pediatric Rheumatology 11:1.
Crossref
Crossref
. 2012. Klinische Immunologie. Klinische Immunologie
e1
e80
.
Cem Evereklioglu. (2011) Ocular Behçet disease. Current Opinion in Ophthalmology 22:6, pages 508-516.
Crossref
Crossref
Marc D. de Smet, Simon R.J. Taylor, Bahram Bodaghi, Elisabetta Miserocchi, Philip I. Murray, Uwe Pleyer, Manfred Zierhut, Talin Barisani-Asenbauer, Phuc LeHoang & Sue Lightman. (2011) Understanding uveitis: The impact of research on visual outcomes. Progress in Retinal and Eye Research 30:6, pages 452-470.
Crossref
Crossref
James T Rosenbaum. (2010) Future for biological therapy for uveitis. Current Opinion in Ophthalmology 21:6, pages 473-477.
Crossref
Crossref
RA Hickman, AK Denniston, C-S. Yee, V. Toescu, PI Murray & C. Gordon. (2009) Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapy. Lupus 19:3, pages 327-329.
Crossref
Crossref
Robert B. Nussenblatt. 2010. Uveitis. Uveitis
332
354
.
Robert B. Nussenblatt. 2010. Uveitis. Uveitis
76
113
.